Abhiram Rao is a Director at EQT Life Sciences, a global investment fund targeting innovative life science companies that has raised over $3Bn. Based in Boston, he helps lead and oversee investments in biotechnology companies across stages. Prior to EQT, Abhiram was at Matrix Capital, where he was responsible for a number of investments in private and public life sciences companies and served on several boards. In addition, he has held roles in strategy and R&D at Tempus, Illumina, and startups in biotechnology and genomics. Abhiram holds a PhD in Bioengineering from Stanford University where his research focused on early-stage drug discovery leveraging computational and high-throughput experimental technologies. He is an author on over 30 papers in journals including Science and Nature Genetics.